Leap Therapeutics Inc (LPTX)

HEALTH CARE: PHARMACEUTICALS
SIC: PHARMACEUTICAL PREPARATIONS

47 THORNDIKE STREET CAMBRIDGE, MA 02142

Leap Therapeutics is focused on developing targeted and immuno-oncology therapeutics. Leap's most advanced clinical candidate, DKN-01, is a humanized monoclonal antibody targeting the Dickkopf-1 (DKK1) protein, a Wnt pathway modulator. DKN-01 is in clinical trials in patients with esophagogastric, hepatobiliary, gynecologic, and prostate cancers. Leap has entered into a strategic partnership with BeiGene, Ltd. for the rights to develop DKN-01 in Asia (excluding Japan), Australia, and New Zealand.

Data as of 2021-08-02 08:53:59 -0400
Market Cap84.734 Million Shares Outstanding59.672 Million Avg 30-day Volume252.169 Thousand
P/E Ratio Dividend Yield EPS
Price/Sales Debt to Equity EBITDA
Price to Book Value0.0 Forward PE Enterprise Value
Total Cash Current Debt Gross Profit
BETA0.63261 52-week High/Low3.24 / 1.33 Next Earnings Date2021-08-12 Price to Cash FLow (P/CF) -10.7166
Data provided by IEX Cloud
View SEC Filings from LPTX instead.
Q1 2021 All 13F Filers Prior Change Hedge Funds 1 Prior Change
In top 10: 0 0 0 (0.0%) 0 (0.0%)
Funds Holding: 48 52 -7.69% 17 (1.0%) 18 (1.04%) -5.56%
13F shares: 22.637 Million 24.433 Million -7.35% 16.311 Million 17.406 Million -6.29%
% Ownership 37.9449 40.9558 -7.35% 27.3416 29.1757 -6.29%
New Positions: 7 18 -61.11% 2 5 -60.0%
Increased Positions 13 13 0.0% 5 5 0.0%
Closed Positions 11 9 22.22% 3 5 -40.0%
Reduced Positions 17 10 70.0% 8 5 60.0%
Total Calls 512.736 Thousand 512.736 Thousand
Total Puts
PUT/CALL Ratio 0.0 0.0
1 hedge funds and active managers as identified by whalewisdom.com through public filings.

View recent insider trading info

Funds Holding LPTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding LPTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MIRABELLI CHRISTOPHER

  • Director
  • 10% Owner
30,000 2021-05-26 4

ONSI DOUGLAS E CEO,CFO,PRES.,GC,TREAS.,&SEC.

  • Officer
  • Director
  • 10% Owner
30,000 2021-05-26 4

LAWLOR AUGUSTINE CHIEF OPERATING OFFICER

  • Officer
  • 10% Owner
30,000 2021-05-26 4

O'MAHONY JOHN MARK CHIEF MANUFACTURING OFFICER

  • Officer
30,000 2021-05-26 3

SIRARD CYNTHIA CHIEF MEDICAL OFFICER

  • Officer
30,000 2021-05-26 3

GRANFIELD CHRISTINE VP, HEAD OF REG AFFAIRS/QUAL

  • Officer
30,000 2021-05-26 3

CAVANAUGH JAMES H

  • Director
0 2021-02-09 3

HEALTHCARE VENTURES IX, L.P.

HEALTHCARE PARTNERS IX, L.P.

HEALTHCARE PARTNERS IX, LLC

  • 10% Owner
No longer subject to file 2021-02-09 1

MASHIACH NISSIM

  • Director
0 2021-01-04 2

LOSCALZO JOSEPH

  • Director
0 2021-01-04 2

DIETZ THOMAS JOHN

  • Director
0 2021-01-04 2

LI WILLIAM

  • Director
0 2021-01-04 2

HEALTHCARE VENTURES VIII, L.P.

HEALTHCARE PARTNERS VIII, LLC

HEALTHCARE PARTNERS VIII, L.P.

  • 10% Owner
No longer subject to file 2020-12-28 1

PERCEPTIVE ADVISORS LLC

PERCEPTIVE LIFE SCIENCES MASTER FUND LTD

EDELMAN JOSEPH

  • 10% Owner
8,476,496 2020-06-22 0

BEIGENE, LTD.

  • 10% Owner
4,804,637 2020-03-12 0

LITTLECHILD JOHN W

  • Director
  • 10% Owner
0 2020-03-02 0

BERTAGNOLLI MONICA

  • Director
0 2018-12-05 0

LILLY ELI & CO

  • 10% Owner
0 2018-07-30 0

WERNER HAROLD R

  • 10% Owner
0 2018-07-30 0

HEALTHCARE VENTURES VIII, L.P.

HEALTHCARE PARTNERS VIII, L.P.

HEALTHCARE PARTNERS VIII, LLC

WERNER HAROLD R

  • 10% Owner
2,618,406 2017-01-20 0

HEALTHCARE VENTURES IX, L.P.

HEALTHCARE PARTNERS IX, LLC

  • 10% Owner
2,515,607 2017-01-20 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days
No current insider transactions

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
LEAP THERAPEUTICS INC LPTX 2021-08-02 22:15:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 21:45:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 21:15:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 20:45:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 20:15:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 19:45:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 19:15:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 18:45:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 18:15:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 17:45:03 UTC -4.2005 4.2605 1200000
LEAP THERAPEUTICS INC LPTX 2021-08-02 17:15:03 UTC -4.2005 4.2605 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 16:45:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 16:15:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 15:45:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 15:15:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 14:45:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 14:15:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 13:45:03 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 13:15:04 UTC -4.2022 4.2822 1300000
LEAP THERAPEUTICS INC LPTX 2021-08-02 12:45:03 UTC -4.2022 4.2822 1300000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments